Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice.
about
Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discoveryFluid-phase pinocytosis of native low density lipoprotein promotes murine M-CSF differentiated macrophage foam cell formationAntagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosisMacrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis11β-hydroxysteroid dehydrogenase type 1 gene knockout attenuates atherosclerosis and in vivo foam cell formation in hyperlipidemic apoE⁻/⁻ miceMacrophage sortilin promotes LDL uptake, foam cell formation, and atherosclerosisEndoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formationMultimolecular signaling complexes enable Syk-mediated signaling of CD36 internalizationMacrophages in the pathogenesis of atherosclerosisMacrophages create an acidic extracellular hydrolytic compartment to digest aggregated lipoproteins.Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particlesScavenger receptor structure and function in health and disease.Oxidized Lipoprotein Uptake Through the CD36 Receptor Activates the NLRP3 Inflammasome in Human Retinal Pigment Epithelial Cells.The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression.CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.Type 2 scavenger receptor CD36 in platelet activation: the role of hyperlipemia and oxidative stress.Induction of ER stress in macrophages of tuberculosis granulomas.Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation.Macrophage death and defective inflammation resolution in atherosclerosis.CD36, a scavenger receptor implicated in atherosclerosis.Oxidized LDL: diversity, patterns of recognition, and pathophysiology.Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African AmericansIdentification and validation of genes affecting aortic lesions in miceMacrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosisThe role of endoplasmic reticulum stress in the progression of atherosclerosis.Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells.Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular diseaseLeukocyte behavior in atherosclerosis, myocardial infarction, and heart failure.Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress.Macrophages in atherosclerosis: a dynamic balance.Albumin-based microbubbles bind up-regulated scavenger receptors following vascular injury.A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signallingInflammatory therapeutic targets in coronary atherosclerosis-from molecular biology to clinical application.OxLDL or TLR2-induced cytokine response is enhanced by oxLDL-independent novel domain on mouse CD36Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice.Deficiency of PXR decreases atherosclerosis in apoE-deficient mice.The phosphoinositide 3-kinase signaling pathway is involved in the control of modified low-density lipoprotein uptake by human macrophagesMurine bone marrow-derived macrophages differentiated with GM-CSF become foam cells by PI3Kγ-dependent fluid-phase pinocytosis of native LDL.LDL Receptor-Related Protein-1 (LRP1) Regulates Cholesterol Accumulation in Macrophages.
P2860
Q21285000-12EDB07F-E9AA-4F6C-A84E-23E36B654AD5Q21558503-42671128-E231-4179-9FDD-9992F7EFF629Q24634165-05220235-862A-4C88-BB3B-A10DDC3DFE91Q26738772-74FD263A-90E9-4CC0-9327-81F26A131B94Q27322801-B0C6C006-D3DF-41F1-866D-96022D1C2DD6Q28255651-40B42A40-F435-49FE-9D3D-015291BC2A66Q28260494-199A51C8-6BA1-4B5E-BE49-C0B0D9C2F19DQ28589223-6767923C-0AF8-4DC5-A3CE-4C781033F64BQ29617765-F241F8F2-8153-453F-9862-54E03FC3691AQ30492073-69C5F3C8-AB06-4631-BFEC-043C7F99546EQ30559538-512420CF-D47C-4871-AD0A-56C870F1B67DQ30587665-90366E81-7C8A-44D7-8F8E-BEE8AD4EE3C8Q30958610-021CBC5D-401C-4352-828E-E864C9B44BE6Q30981897-9F5CDD8D-E651-4D9A-9AFC-D3E6070C58C1Q33586616-CA728113-8818-4B61-A885-121CB24D7B3CQ33609100-C1EFD27D-E3FF-4BD5-83D5-4196ACAA6B46Q33641499-14733855-9FC4-4AA8-8DA5-6DF77A72BEEFQ33697646-9E4CFCAD-8DAB-42C6-8330-49786E7ABFE4Q33752256-4B77B83C-597E-4839-9192-C70369BD6B06Q33789327-7A6FEB4C-25C3-40CA-8B1F-E70E127CFF65Q33844864-18973AED-14E6-40AD-97A4-BEF7FC724F07Q33879138-F8CD7764-DA13-4EE0-B45D-502F79DD7AF5Q33925367-514CC2B6-DC58-4B40-9270-DD365D9C62A6Q33968151-85D2F97E-1A20-4D57-8A41-256F77669BBAQ34004031-3782F8DD-2C96-4238-BAC2-E68166D38839Q34141006-DEC81C80-5895-4A31-9878-00BAFC6E13ECQ34217939-99D07437-1946-48EA-AD1B-85B83E1629DEQ34218552-6FBB4649-836C-4745-B81E-A9488461740FQ34322056-6240820B-CD22-4FB4-BA92-0868C9F9EF51Q34346809-454E8569-5FE3-4174-BDA4-BBBAD77DFE5FQ34368005-FA0722DE-8C54-44E3-A54E-F3E68A2C4E69Q34412613-489D01CE-A0CE-45FF-89E5-8CAB7A2D2E32Q34530236-16C4C595-FC51-4ACF-BD7A-84BF018983EAQ34554918-8CB785D6-1E94-4FE4-A985-5567E021D0D5Q34803791-7AD46CCF-2E8F-4CDA-AD03-727D73049973Q35044164-0F382116-A1A3-4A82-B361-D2ED0D76C6E9Q35152206-38F4E75D-6965-46F7-B3E4-8EBE1BBEC8B4Q35557995-2EB7EBA2-9B05-4C58-B0B6-DAFC39033AD3Q35627821-9502DC66-1E6E-4757-8030-67556FB8621BQ35659751-ABD50200-0FFA-4591-9D87-9AC1189E7553
P2860
Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Loss of SR-A and CD36 activity ...... mation in hyperlipidemic mice.
@en
Loss of SR-A and CD36 activity ...... mation in hyperlipidemic mice.
@nl
type
label
Loss of SR-A and CD36 activity ...... mation in hyperlipidemic mice.
@en
Loss of SR-A and CD36 activity ...... mation in hyperlipidemic mice.
@nl
prefLabel
Loss of SR-A and CD36 activity ...... mation in hyperlipidemic mice.
@en
Loss of SR-A and CD36 activity ...... mation in hyperlipidemic mice.
@nl
P2093
P2860
P1476
Loss of SR-A and CD36 activity ...... mation in hyperlipidemic mice.
@en
P2093
Jacqueline I Alvarez-Leite
Jennifer J Manning-Tobin
Maia Sharuk
Mason W Freeman
Menno P J de Winther
Susan A Bell
Tracie A Seimon
P2860
P356
10.1161/ATVBAHA.108.176644
P407
P577
2008-10-23T00:00:00Z